Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: Continuous infusion and bolus injection

• المؤلفون الرئيسيون: A. Chuansumrit, P. Isarangkura, P. Angchaisuksiri, N. Sriudomporn, K. Tanpowpong, P. Hathirat, L. N. Jorgensen
• مؤلفون آخرون: Faculty of Medicine, Ramathibodi Hospital, Mahidol University
• التنسيق: مقال
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://repository.li.mahidol.ac.th/handle/123456789/26259
• المؤسسة: Mahidol University

The efficacy of recombinant activated factor VII (rFVIIa, NovoSeven) in five haemophiliacs (four haemophilia A, one haemophilia B), with high inhibitors ranging from 70 to 1900 Bethesda units, was evaluated. The treatment regimen was divided into two groups: group I, continuous infusion of 16.5 μg h...